Stein, K and Rosenberg, W and Wong, J (2002) Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut , 50 (2) 253 - 258.
Full text not available from this repository.
Abstract
To estimate the cost utility of treatment with combination therapy (ribavirin and interferon alpha) for hepatitis C compared with no treatment or monotherapy (interferon alpha) based on UK costs and clinical management.
| Type: | Article |
|---|---|
| Title: | Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. |
| Location: | England |
| Language: | English |
| Additional information: | PMCID: PMC1773115 |
| Keywords: | Adult, Aged, Antiviral Agents, Cohort Studies, Cost-Benefit Analysis, Decision Support Techniques, Drug Combinations, Female, Health Resources, Health Status, Hepatitis C, Chronic, Humans, Interferon-alpha, Liver Transplantation, Male, Markov Chains, Middle Aged, Quality-Adjusted Life Years, Ribavirin, Sensitivity and Specificity |
Archive Staff Only: edit this record